519172-79-3

Basic information

• Product Name: CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI)
• Synonyms: CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI);N'-(4-Fluorobenzyl)ethane-1,2-diamine, N-BOC protected;tert-Butyl {2-[(4-fluorobenzyl)amino]ethyl}carbamate;tert-Butyl N-[2-[(4-fluorophenyl)methylamino]ethyl]carbamate
• CAS NO: 519172-79-3
• Molecular Formula: C₁₄H₂₁FN₂O₂
• Molecular Weight: 268.3271432
• Mol File: 519172-79-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI)(519172-79-3)
• EPA Substance Registry System: CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI)(519172-79-3)

Safety Data

• Hazardous Substances Data: 519172-79-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI) is used as a chemical intermediate for the synthesis of potential drug candidates. Its unique chemical structure, including the presence of an amino group and an ester bond, makes it a promising candidate for further study and evaluation in pharmaceutical and medicinal chemistry.
Used in Medicinal Chemistry:
CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI) is used as a starting material for the development of new pharmaceutical compounds. Its fluorophenylmethylaminoethyl group and ester bond may contribute to its biological activity, making it a valuable component in the design and synthesis of novel therapeutic agents.
Note: The specific applications and industries for CarbaMic acid, [2-[[(4-fluorophenyl)Methyl]aMino]ethyl]-, 1,1-diMethylethyl ester (9CI) are not provided in the materials. The uses listed above are based on the general information provided about the compound's role in pharmaceutical research and development and medicinal chemistry.

Upstream product

• 57260-73-8 N-BOC-1,2-diaminoethane 
• 459-57-4 4-fluorobenzaldehyde 

Downstream Products

• 895134-30-2 (2-((3-benzyloxy-6-(tert-butyl-dimethyl-silanyloxymethyl)-4-oxo-4H-pyrane-2-carbonyl)-(4-fluoro-benzyl)-amino)-ethyl)-carbamic acid tert-butyl ester 
• 2070-85-1 N¹-4-fluorobenzylethane-1,3-diamine 
• 500782-66-1 (S)-1-(4-fluorobenzyl)-3-Isobutylpiperazin-2-one 

Relevant articles and documents

Synthesis of 1- and 4-substituted piperazin-2-ones via Jocic-type reactions with N-substituted diamines

Enantiomerically-enriched trichloromethyl-containing alcohols, obtained by asymmetric reduction, can be transformed regioselectively into 1-substituted piperazinones by modified Jocic reactions with little or no loss of stereochemical integrity. This meth

Methods of using piperazine derivatives

The present invention relates to compounds of the formula I and the pharmaceutically acceptable forms thereof; wherein X, Y, a, b, c, d, R1, R2, R3, R4 and R5 are as defined herein. Moreover, the present invention is also directed at pharmaceutical compositions comprising a compound of the formula I and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed at methods of using the herein described compounds and compositions for treating or preventing a disorder or condition that can be treated or prevented by antagonizing the CCR1 receptor in a mammal.